Sarcoma Study Details

Reference

NCT02601937

 Short title

A Phase I Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects with Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma


Australian Sites

Children's Hospital at Westmead, Lady Cilento Children's Hospital, Royal Children's Hospital Melbourne, Sydney Children's Hospital


 Open
2016
Contacts

Contact: Sydney Children's Hospital - Shelley Burnett, shelley.burnett@health.nsw.gov.au;
Lady Cilento Children's Hospital - Jackie Seljak, jackie.seljak@health.qld.gov.au,
The Royal Children's Hospital - Ryan Hehir; ryan.hehir@mcri.edu.au 


 Go back to Sarcoma Studies